Log In
BCIQ
Print this Print this
 

ATIR (ATIR101)

Also known as: formerly Theralux-ATIR

  Manage Alerts
Collapse Summary General Information
Company Kiadis Pharma N.V.
DescriptionCell-based therapy containing mismatched donor lymphocytes depleted of alloreactive T cells
Molecular Target Not applicable
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Non-stem cell

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$1.8M

$1.0M

0


 Deals Details
Get a free BioCentury trial today